Boothbay Fund Management’s Verrica Pharmaceuticals VRCA Stock Holding History

Boothbay Fund Management’s Portfolio VRCA Stock Details VRCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.49M	Hold	280,734	–	–	0.03%	757
2025 Q4	$2.33M	Hold	280,734	–	–	0.06%	518
2025 Q3	$1.21M	Buy	+280,734	New	+$1.69M	0.03%	755
2025 Q2	–	Sell	-280,735	Closed	-$1.24M	–	1844
2025 Q1	$1.24M	Buy	280,735 +22,030	+9%	+$142K	0.04%	559
2024 Q4	$1.81M	Buy	+258,705	New	+$2.84M	0.05%	475
2022 Q3	–	Sell	-1,667	Closed	-$32K	–	2688
2022 Q2	$32K	Buy	+1,667	New	+$83.8K	﹤0.01%	2155

Other funds holding VRCA

Caligan Partners New York $1.41B AUM 518.95% 1-Year Est. Return

Affinity Asset Advisors New York $1.71B AUM 374.45% 1-Year Est. Return

Cannell Capital Alta, Wyoming $154M AUM 40.62% 1-Year Est. Return

Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return